发明名称 |
MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-122 |
摘要 |
Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions. |
申请公布号 |
US2015105449(A1) |
申请公布日期 |
2015.04.16 |
申请号 |
US201414577481 |
申请日期 |
2014.12.19 |
申请人 |
REGULUS THERAPEUTICS INC. |
发明人 |
Bhat Balkrishen;Hogan Daniel |
分类号 |
C12N15/113;A61K47/48 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound comprising a modified oligonucleotide consisting of 16 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-122 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 16 contiguous nucleosides of the following nucleoside pattern I in the 5′ to 3′ orientation:
(R)X—NQ—NQ—NB—NB—NQ—NB—NQ—NB—NQ—NB—NB—(NZ)Y wherein each R is, independently, a non-bicyclic nucleoside or a bicyclic nucleoside; X is from 4 to 10; each NB is, independently, a bicyclic nucleoside; each NQ is, independently, a non-bicyclic nucleoside; Y is 0 or 1; and NZ is a modified nucleoside or an unmodified nucleoside. |
地址 |
San Diego CA US |